Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Börse Stuttgart
Equities
2TZ
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.196 EUR | -2.27% |
|
-6.28% | +21.02% |
May. 15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Business Summary
Number of employees: 4,619
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chinese Patent Medicine
71.0
%
| 5,652 | 68.5 % | 5,836 | 71.0 % | +3.26% |
Western Medicine
20.6
%
| 1,783 | 21.6 % | 1,697 | 20.6 % | -4.84% |
Other
8.2
%
| 796 | 9.7 % | 673 | 8.2 % | -15.47% |
Other Business
0.2
%
| 18 | 0.2 % | 16 | 0.2 % | -9.16% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.5
%
| 8,198 | 99.6 % | 8,161 | 99.5 % | -0.44% |
Overseas
0.5
%
| 34 | 0.4 % | 45 | 0.5 % | +33.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Jian Ma
DFI | Director of Finance/CFO | 46 | 23-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Ming Jie Shang
BRD | Director/Board Member | 55 | 23-02-28 |
42 | - | ||
54 | - | ||
Jian Wang
IRC | Investor Relations Contact | - | - |
51 | - | ||
- | - | ||
61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guat Kwang Yeo
BRD | Director/Board Member | 63 | Nov. 27 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 53 | 21-12-09 |
Mai Wang
BRD | Director/Board Member | 54 | 17-07-31 |
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Li Qing
BRD | Director/Board Member | 57 | 21-05-16 |
Min Guo
BRD | Director/Board Member | 53 | 21-09-05 |
Ming Rui Zhang
CHM | Chairman | 49 | 21-12-27 |
Wei Wen Mao
BRD | Director/Board Member | 50 | 22-12-29 |
Ming Jie Shang
BRD | Director/Board Member | 55 | 23-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 200,000,000 | 0 | 0 | 31.14 % |
Stock B | 1 | 570,158,276 | 239,803,030 ( 42.06 %) | 1,285,200 ( 0.2254 %) |
Company contact information
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
No. 17 Baidi Road Nankai District
300193, Tianjin
+
http://en.pharm.com.cn![address Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(2TZ)](https://cdn.zonebourse.com/static/address/50916023.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.14% | 5.87B | |
-30.04% | 3.71B | |
-22.68% | 2.71B | |
-8.17% | 2.36B | |
+42.02% | 1.89B | |
+45.22% | 1.5B | |
-12.58% | 1.44B | |
+40.95% | 1.35B | |
-27.42% | 1.32B |
- Stock Market
- Equities
- 600329 Stock
- 2TZ Stock
- Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited